NCT01384435View on ClinicalTrials.gov

A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

Not specified

Conditions
SCD
Interventions
DRUG

KPS-0373

DRUG

KPS-0373

DRUG

KPS-0373

DRUG

KPS-0373

DRUG

Placebo

Trial Locations (1)

Unknown

Japan, Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY